Showing results (301-310 of 426) with videos related to

Sort By:
Pageof 43
JACC. Heart Failure|September 1, 2022
Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of VericiguatPaul W Armstrong, Yinggan Zheng, Richard W Troughton, et al.
European Journal of Heart Failure|September 12, 2015
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysisJoanne Simpson, Davide Castagno, Rob N Doughty, et al.
Journal of Cardiac Failure|January 31, 2025
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID TrialJustin A Ezekowitz, Hillary Mulder, Robert J Mentz, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Journal of Heart Failure|December 22, 2017
Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HFSean D Pokorney, Sana M Al-Khatib, Jie-Lena Sun, et al.
Circulation. Heart Failure|January 30, 2025
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing SubanalysisW H Wilson Tang, Yuxi Liu, Javed Butler, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
European Journal of Heart Failure|March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk scoreChristopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
Pageof 43